The Prognostic Roles of Perihematomal Edema and Ventricular Size in Patients with Intracerebral Hemorrhage
- PMID: 35676589
- DOI: 10.1007/s12028-022-01532-0
The Prognostic Roles of Perihematomal Edema and Ventricular Size in Patients with Intracerebral Hemorrhage
Abstract
Background: Conflicting data exist regarding the association of perihematomal edema (PHE) with outcomes after intracerebral hemorrhage (ICH). We performed a post hoc analysis of the ICH Deferoxamine trial to examine whether an early change in ventricular size (VS), as a composite measure of PHE growth and mass effect, intraventricular hemorrhage, and hydrocephalus, is a more accurate predictor of outcome than PHE measures alone.
Methods: Computerized tomography scans were performed at baseline and after 72-96 h. We evaluated measures of PHE and change in VS as predictors of outcome, assessed by a dichotomized modified Rankin Scale score (0-2 versus 3-6), primarily at 90 days and secondarily at 30 days. A multivariable logistic regression model was fitted for each predictor, with adjustment for the same confounders.
Results: A total of 248 participants were included after we excluded those requiring external ventricular drains. On univariate analyses, older age, female sex, lower Glasgow Coma Scale score and baseline temperature, greater ICH volume, absolute PHE volume, edema extension distance at presentation, lesser changes in relative PHE volume and edema extension distance, and an increase in VS were associated with poor outcome. In multivariable analyses, only the increase in VS was associated with lower odds of modified Rankin Scale scores 0-2 at 90 days (odds ratio 0.927, 95% confidence interval 0.866-0.970, p = 0.001) and 30 days (odds ratio 0.931, 95% confidence interval 0.888-0.975, p = 0.003).
Conclusions: Within the context of a randomized controlled trial with standardized imaging and functional assessments, we did not find significant associations between measures of PHE and outcome but documented an independent association between early increase in VS and lower odds of good clinical outcome.
Trial registration: ClinicalTrials.gov NCT02175225.
Keywords: Cerebral hemorrhage; Hemorrhagic stroke; Prognosis; Stroke.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.
References
-
- Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral haemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24(7):987–93. https://doi.org/10.1161/01.str.24.7.987 . - DOI - PubMed
-
- Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175. https://doi.org/10.1212/01.wnl.0000208408.98482.99 . - DOI - PubMed
-
- Brian TA, Bennie WC, Walter LO, Lawrence HP. The effect of intracerebral hematoma location on the risk of brain-stem compression and on clinical outcome. J Neurosurg. 1988;69(4):518–22. https://doi.org/10.3171/jns.1988.69.4.0518 . - DOI
-
- Sreekrishnan A, Dearborn JL, Greer DM, et al. Intracerebral Hemorrhage location and functional outcomes of patients: a systematic literature review and meta-analysis. Neurocrit Care. 2016;25(3):384–91. https://doi.org/10.1007/s12028-016-0276-4 . - DOI - PubMed
-
- Christensen Michael C, Mayer S, Ferran J-M. Quality of Life After Intracerebral Hemorrhage. Stroke. 2009;40(5):1677–82. https://doi.org/10.1161/STROKEAHA.108.538967 . - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
